Additional Information:
2010 Frequently Asked Questions
Sample Logic Model

Harold Rogers Prescription Drug Monitoring Program FY 2009 Grant Awards

Announcements:
The November-December 2009 PDMP Training and Technical Assistance Newsletter is now available!

• Past Issues:
  September-October 2009
  July-August 2009
  May-June 2009
  March-April 2009
  January-February 2009
  

The Harold Rogers Prescription Drug Monitoring Program National Meeting was held on September 24-25, 2009 in Washington, DC. The agenda and presentations are available at: www.pmpalliance.org/national_meeting_2009.

BJA has released the Guidance for Grantees on Responding to Performance Measures that offers common definitions and guidance related to the performance metrics questions.

Overview:
Beginning in FY 2002, Congress appropriated funding to the U.S. Department of Justice to support the Prescription Drug Monitoring Program. Prescription monitoring programs help prevent and detect the diversion and abuse of pharmaceutical controlled substances, particularly at the retail level where no other automated information collection system exists. States that have implemented prescription monitoring programs have the capability to collect and analyze prescription data much more efficiently than states without such programs, where the collection of prescription information requires the manual review of pharmacy files, a time-consuming and invasive process.

The purpose of the Prescription Drug Monitoring Program is to enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data. The program focuses on providing help for states that want to establish a prescription drug monitoring program. Resources are also available to states that wish to expand their existing programs. Program objectives include:

• Building a data collection and analysis system at the state level.
• Enhancing existing programs' ability to analyze and use collected data.
• Facilitating the exchange of collected prescription data among states.
• Assessing the efficiency and effectiveness of the programs funded under this initiative.

PDMP Evaluation
In partnership with BJA, Simeone Associates released An Evaluation of Prescription Drug Monitoring Programs, which examines the effects of such programs on the supply and abuse of prescription drugs. At the time of the study, 20 states had implemented and 23 states were in the process or designing or planning systems to monitor the prescription and sale of drugs identified as controlled substances by the U.S. Drug Enforcement Administration. (Executive Summary)

Legislation: The Prescription Drug Monitoring Program was created by the FY 2002 U.S. Department of Justice Appropriations Act (Public Law 107-77).

Funding: FY 2009 funding was $7 million.

Eligibility: Applicants are limited to the 50 U.S. states, the District of Columbia, Commonwealth of Puerto Rico, Northern Mariana Islands, Virgin Islands, Guam, and American Samoa with legislation or regulations, either pending or in place, that (1) require the submission of dispensing data to a centralized database and (2) authorize or designate a state agency to implement and administer the program. State governments that want to improve an existing prescription drug monitoring program may apply for an enhancement award. States that want to apply for a planning grant do not need to have legislation or a regulation in place or pending.

How/When To Apply: BJA released the FY 2010 solicitation on February 2, 2010, and applications are due on April 1, 2010 via Grants Management System (GMS).

For technical assistance, contact the Training and Technical Assistance Center at 360-556-7152 or visit the www.pmpalliance.org.

BJA also provides funding to several other partners to support PDMP-related projects.

• The National Alliance for Model State Drug Laws provides states with necessary legislative and policy resources.
  
• The IJIS Institute is currently working with BJA on a project related to information sharing between PDMPs. Phase I of the project involved defining the prescription monitoring information exchange (PMIX) specifications to guide the implementation of systems that exchange data between states. For Phase II, IJIS implemented a pilot test between two states for exchanging PDMP data. Based on the success of Phase II, work is now beginning on Phase III which will involve utilizing a hub server to centrally facilitate and broker PMIX exchanges.


• In FY 2006, BJA awarded a grant to the National Conference of State Legislators to educate state legislators and key legislative staff on the policy issues associated with PDMPs. For more information about NCSL's work on PDMPs, visit www.ncsl.org/programs/cj/pdmp.htm.
• In FY 2006, BJA also awarded a grant to the Addiction Technology Transfer Center (ATTC) National Office to develop resources to strengthen the linkages between state PDMPs and state addiction treatment agencies. Information can be found on the The ATTC Website dedicated to PDMPs.

Related Information:
Harold Rogers Prescription Drug Monitoring Program (FY 2009 Competitive Grant Announcement)

FY 2008 Grant Awards
Harold Rogers Prescription Drug Monitoring Training and Technical Assistance Program (FY 2008 Competitive Grant Announcement)
Developing and Enhancing Prescription Drug Monitoring Programs (FY 2008 Competitive Grant Announcement)
Frequently Asked Questions

FY 2007 Grant Awards
Developing and Enhancing Prescription Drug Monitoring Programs (FY 2007 Competitive Grant Announcement)
Frequently Asked Questions

FY 2006 Prescription Drug Monitoring Program Grant Awards
Developing and Enhancing Prescription Drug Monitoring Programs (FY 2006 Competitive Grant Announcement)

FY 2005 Prescription Drug Monitoring Program Grant Awards
Developing and Enhancing Prescription Drug Monitoring Programs (FY 2005 Competitive Grant Announcement)

FY 2004 Prescription Drug Monitoring Program Grant Awards

FY 2003 Prescription Drug Monitoring Program Grant Awards

Additional Resources:
Prescription Drug Monitoring Programs At-A-Glance
Prescription Drug Monitoring Program Fact Sheet
Status of State PDMPs

Related Federal and National Resources:
Alliance of States with Prescription Drug Monitoring Programs
Drug Enforcement Administration
National Alliance for Model State Drug Laws
National Association of State Controlled Substances Authorities
National Conference of State Legislators

Contact Information:
Rebecca Rose
Policy Advisor for Substance Abuse and Mental Health
Bureau of Justice Assistance
810 Seventh Street NW.
Washington, DC 20531
(202) 514-0726
Fax: (202) 307-0036
E-mail: Rebecca.Rose@usdoj.gov